Compare TMS & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TMS | CGC |
|---|---|---|
| Founded | 2019 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | Pharmaceuticals and Biotechnology |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 482.4M | 389.2M |
| IPO Year | 2025 | 2023 |
| Metric | TMS | CGC |
|---|---|---|
| Price | $5.50 | $0.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $12.88 | N/A |
| AVG Volume (30 Days) | 142.4K | ★ 2.3M |
| Earning Date | 11-24-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 84.17 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $12,759,000.00 |
| Revenue This Year | $41.62 | $21.39 |
| Revenue Next Year | $70.99 | $8.33 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.04 | $0.69 |
| 52 Week High | $10.42 | $2.38 |
| Indicator | TMS | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 35.70 | 29.22 |
| Support Level | $5.31 | N/A |
| Resistance Level | $9.58 | $1.08 |
| Average True Range (ATR) | 0.67 | 0.04 |
| MACD | -0.25 | -0.01 |
| Stochastic Oscillator | 17.96 | 25.51 |
Teamshares Inc is a tech-enabled company that acquires and operates small and medium-sized businesses. It uses a software platform to support activities across the acquisition lifecycle, including sourcing, evaluation, and transaction execution. After acquisition, the platform is used to integrate financial and operational data and to monitor performance across its portfolio companies. The company has two reportable segments: Small Business Acquisitions and Real Estate. The majority of revenue is derived from the Small Business Acquisitions, which includes all of the Operating Subsidiaries owned by the company.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.